ArticleChinese medical journal2026

Disease burden of hematological malignancies worldwide, in China and in the United States based on the GLOBOCAN 2022 and Global Burden of Disease 2021 data.

Minghao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.